| Outcome and prognostic factors in olfactory neuroblastoma: a rare cancer network study M Ozsahin, G Gruber, O Olszyk, O Karakoyun-Celik, B Pehlivan, D Azria, ... International Journal of Radiation Oncology* Biology* Physics 78 (4), 992-997, 2010 | 109 | 2010 |
| Temporal lobe toxicity analysis after proton radiation therapy for skull base tumors B Pehlivan, C Ares, AJ Lomax, O Stadelmann, G Goitein, B Timmermann, ... International Journal of Radiation Oncology* Biology* Physics 83 (5), 1432-1440, 2012 | 74 | 2012 |
| Pseudoprogression in patients with glioblastoma multiforme after concurrent radiotherapy and temozolomide E Topkan, S Topuk, E Oymak, C Parlak, B Pehlivan American journal of clinical oncology 35 (3), 284-289, 2012 | 73 | 2012 |
| Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy E Topkan, C Parlak, A Kotek, AF Yapar, B Pehlivan BMC gastroenterology 11, 1-9, 2011 | 66 | 2011 |
| Evidence for the approach to the diagnostic evaluation of squamous cell carcinoma occult primary tumors of the head and neck P Golusinski, P Di Maio, B Pehlivan, S Colley, P Nankivell, A Kong, ... Oral oncology 88, 145-152, 2019 | 59 | 2019 |
| Influence of oral glutamine supplementation on survival outcomes of patients treated with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer E Topkan, C Parlak, S Topuk, B Pehlivan BMC cancer 12, 1-10, 2012 | 52 | 2012 |
| Interfractional set-up errors evaluation by daily electronic portal imaging of IMRT in head and neck cancer patients B Pehlivan, C Pichenot, M Castaing, A Auperin, D Lefkopoulos, ... Acta Oncologica 48 (3), 440-445, 2009 | 42 | 2009 |
| Systemic inflammation response index predicts survival outcomes in glioblastoma multiforme patients treated with standard stupp protocol E Topkan, A Kucuk, Y Ozdemir, H Mertsoylu, AA Besen, D Sezen, ... Journal of Immunology Research 2020, 2020 | 33 | 2020 |
| Comparison of CT and integrated PET-CT based radiation therapy planning in patients with malignant pleural mesothelioma B Pehlivan, E Topkan, C Onal, GN Nursal, O Yuksel, Y Dolek, MN Yavuz, ... Radiation Oncology 4, 1-7, 2009 | 23 | 2009 |
| Five-year follow-up results for patients diagnosed with anaplastic astrocytoma and effectiveness of concomitant therapy with temozolomide for recurrent anaplastic astrocytoma F Sarica, M Cekinmez, K Tufan, O Sen, H Onal, H Mertsoylu, E Topkan, ... Asian journal of neurosurgery 7 (04), 181-190, 2012 | 21 | 2012 |
| Impact of Prophylactic Cranial Irradiation Timing on Brain Relapse Rates in Patients With Stage IIIB Non–Small-Cell Lung Carcinoma Treated With Two Different Chemoradiotherapy … E Topkan, C Parlak, A Kotek, O Yuksel, M Cengiz, M Ozsahin, B Pehlivan International Journal of Radiation Oncology* Biology* Physics 83 (4), 1264-1271, 2012 | 20 | 2012 |
| Prognostic value of pretreatment systemic immune-inflammation index in glioblastoma multiforme patients undergoing postneurosurgical radiotherapy plus concurrent and adjuvant … E Topkan, AA Besen, Y Ozdemir, A Kucuk, H Mertsoylu, B Pehlivan, ... Mediators of Inflammation 2020, 2020 | 19 | 2020 |
| Review of osteoradionecrosis of the jaw: radiotherapy modality, technique, and dose as risk factors E Topkan, A Kucuk, E Somay, B Yilmaz, B Pehlivan, U Selek Journal of Clinical Medicine 12 (8), 3025, 2023 | 17 | 2023 |
| Low systemic inflammation response index predicts good prognosis in locally advanced pancreatic carcinoma patients treated with concurrent chemoradiotherapy E Topkan, H Mertsoylu, A Kucuk, AA Besen, A Sezer, D Sezen, ... Gastroenterology Research and Practice 2020, 2020 | 17 | 2020 |
| Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis … F Birol Sarica, K Tufan, M Cekinmez, O Sen, H Cem Onal, H Mertsoylu, ... J Neurosurg Sci 54 (1), 7-19, 2010 | 16 | 2010 |
| Sarcomatoid carcinoma of the urinary bladder treated with adjuvant radiotherapy: a case report C Onal, B Pehlivan, N Bal, E Topkan, F Kilinc, S Topuk Clinical Medicine: Case Reports 2, CCRep. S3126, 2009 | 16 | 2009 |
| Prechemoradiotherapy systemic inflammation response index stratifies stage IIIB/C non-small-cell lung cancer patients into three prognostic groups: a propensity score-matching … E Topkan, U Selek, A Kucuk, V Haksoyler, Y Ozdemir, D Sezen, ... Journal of Oncology 2021, 2021 | 13 | 2021 |
| The influence of systemic inflammation response index on survival outcomes of limited-stage small-cell lung cancer patients treated with concurrent chemoradiotherapy A Kucuk, EE Ozkan, S Eskici Oztep, H Mertsoylu, B Pehlivan, U Selek, ... Journal of Oncology 2020, 2020 | 13 | 2020 |
| Low pre-ChemoradiotherapyPan-immune-inflammation value (PIV) measures predict better survival outcomes in locally advanced pancreatic adenocarcinomas E Topkan, U Selek, A Kucuk, B Pehlivan Journal of Inflammation Research, 5413-5423, 2022 | 12 | 2022 |
| Initial neutrophil‐to‐lymphocyte ratio predicts radiation‐induced trismus in parotid gland cancer E Somay, B Yilmaz, E Topkan, A Kucuk, B Pehlivan, U Selek Oral Diseases 29 (7), 2772-2779, 2023 | 10 | 2023 |
